Answers are grounded in this paper and cite their sources.
Emission enhancement and application of GFPc analogs are achieved via chemical modification or physical encapsulation due to conformational motion inhibition.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: